Page last updated: 2024-09-05

phosphatidylcholines and Bone Loss, Osteoclastic

phosphatidylcholines has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demer, LL; Effros, RB; Graham, LS; Kitchen, CM; Parhami, F; Tintut, Y1
Cruess, RL; Hong, KC; Nakamura, F1

Other Studies

2 other study(ies) available for phosphatidylcholines and Bone Loss, Osteoclastic

ArticleYear
Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss.
    Clinical immunology (Orlando, Fla.), 2009, Volume: 133, Issue:2

    Topics: Animals; Bone Density; Bone Resorption; Cell Nucleus; Dietary Fats; Dinoprostone; Gene Expression; Humans; Isoprostanes; Lipids; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoprotegerin; Oxidation-Reduction; Phosphatidylcholines; RANK Ligand; Scavenger Receptors, Class E; T-Lymphocytes; Transcription Factor RelA

2009
The effect of parathyroid hormone upon release of degradative enzymes from rat bone.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1979, Volume: 162, Issue:1

    Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Collagen; In Vitro Techniques; Male; Parathyroid Hormone; Phosphatidylcholines; Phospholipids; Rats

1979